MedTrace Logo

Suzetrigine vs Norco-postoperative Mohs Pain

NCT07575230 · Status: ENROLLING_BY_INVITATION · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-05-11

No results posted yet for this study

Summary

To compare suzetrigine versus hydrocodone/acetaminophen for postoperative pain control following dermatologic surgery.

Conditions

  • Cutaneous Tumors
  • Mohs Micrographic Surgery

Interventions

DRUG

Norco 5Mg-325Mg Tablet

Standard of care drug

DRUG

Suzetrigine

Control Drug

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Stan Tolkachjov, MD · Baylor Medical University Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-03
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07575230 on ClinicalTrials.gov